Oruka Therapeutics, Inc. (ORKA) — Working Capital to Net Assets Ratio
Oruka Therapeutics, Inc. (ORKA) has a Working Capital to Net Assets ratio of 68.7% as of September 2025. Working capital of $334.20 Million (current assets of $355.16 Million minus current liabilities of $20.97 Million) is measured against net assets of $486.79 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Oruka Therapeutics, Inc. asset portfolio.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Oruka Therapeutics, Inc. Working Capital to Net Assets (2005–2024)
This chart shows how Oruka Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 68.7%, reflecting working capital of $334.20 Million against net assets of $486.79 Million USD. Explore debt repayment capacity of Oruka Therapeutics, Inc. to assess how comfortably operating cash covers total debt obligations.
Annual Working Capital to Net Assets for Oruka Therapeutics, Inc. (2005–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Oruka Therapeutics, Inc. from 2005 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore long-term investment intensity of Oruka Therapeutics, Inc. to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 95.2% | $363.83 Million | $382.22 Million | $376.87 Million | $13.04 Million | ▼ -4.6 pp |
| 2023 | 99.8% | $36.95 Million | $37.02 Million | $37.59 Million | $637.00K | ▲ +0.1 pp |
| 2022 | 99.7% | $41.57 Million | $41.67 Million | $42.70 Million | $1.13 Million | ▼ 0.0 pp |
| 2021 | 99.8% | $50.92 Million | $51.04 Million | $54.42 Million | $3.50 Million | ▼ -0.1 pp |
| 2020 | 99.9% | $46.47 Million | $46.52 Million | $49.97 Million | $3.50 Million | ▲ +0.6 pp |
| 2019 | 99.3% | $7.55 Million | $7.61 Million | $8.48 Million | $926.00K | ▲ +0.1 pp |
| 2018 | 99.2% | $5.98 Million | $6.03 Million | $6.78 Million | $793.00K | ▼ -0.3 pp |
| 2017 | 99.6% | $10.23 Million | $10.28 Million | $12.30 Million | $2.07 Million | ▲ +13.7 pp |
| 2016 | 85.8% | $19.05 Million | $22.19 Million | $21.45 Million | $2.40 Million | ▼ -12.4 pp |
| 2015 | 98.3% | $37.41 Million | $38.07 Million | $38.92 Million | $1.50 Million | ▲ +2.6 pp |
| 2014 | 95.7% | $14.10 Million | $14.74 Million | $15.49 Million | $1.39 Million | ▼ -3.3 pp |
| 2013 | 99.0% | $15.42 Million | $15.58 Million | $16.93 Million | $1.50 Million | ▲ +4.7 pp |
| 2012 | 94.3% | $2.74 Million | $2.91 Million | $3.04 Million | $305.00K | ▼ -1.0 pp |
| 2011 | 95.2% | $5.46 Million | $5.73 Million | $6.21 Million | $754.00K | ▲ +7.0 pp |
| 2010 | 88.2% | $5.97 Million | $6.77 Million | $7.16 Million | $1.19 Million | ▼ -1.4 pp |
| 2009 | 89.6% | $6.64 Million | $7.41 Million | $8.29 Million | $1.64 Million | ▼ -26.2 pp |
| 2008 | 115.8% | $-6.15 Million | $-5.31 Million | $9.68 Million | $15.83 Million | ▼ -5.1 pp |
| 2007 | 120.9% | $81.80 Million | $67.66 Million | $99.99 Million | $18.19 Million | ▼ -54.5 pp |
| 2006 | 175.4% | $122.50 Million | $69.84 Million | $166.34 Million | $43.84 Million | ▲ +88.0 pp |
| 2005 | 87.3% | $49.58 Million | $56.76 Million | $85.77 Million | $36.18 Million | — |